Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

MIAX vs CME

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MIAX
Miami International Holdings, Inc.

Financial - Capital Markets

Financial ServicesNYSE • US
Market Cap$4.56B
5Y Perf.+10.1%
CME
CME Group Inc.

Financial - Data & Stock Exchanges

Financial ServicesNASDAQ • US
Market Cap$104.07B
5Y Perf.+7.2%

MIAX vs CME — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MIAX logoMIAX
CME logoCME
IndustryFinancial - Capital MarketsFinancial - Data & Stock Exchanges
Market Cap$4.56B$104.07B
Revenue (TTM)$1.36B$6.52B
Net Income (TTM)$-70M$4.24B
Gross Margin27.3%86.1%
Operating Margin2.7%64.9%
Forward P/E34.4x23.5x
Total Debt$2M$3.76B
Cash & Equiv.$510M$4.42B

Quick Verdict: MIAX vs CME

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CME leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Miami International Holdings, Inc. is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
MIAX
Miami International Holdings, Inc.
The Banking Pick

MIAX is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 19.6%, EPS growth -177.5%
  • Lower volatility, beta 0.62, Low D/E 0.2%, current ratio 491.63x
  • Beta 0.62, current ratio 491.63x
Best for: growth exposure and sleep-well-at-night
CME
CME Group Inc.
The Banking Pick

CME carries the broadest edge in this set and is the clearest fit for long-term compounding.

  • 284.9% 10Y total return vs MIAX's 61.8%
  • Lower P/E (23.5x vs 34.4x)
  • Efficiency ratio 0.2% vs MIAX's 0.2% (lower = leaner)
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthMIAX logoMIAX19.6% NII/revenue growth vs CME's 6.4%
ValueCME logoCMELower P/E (23.5x vs 34.4x)
Quality / MarginsCME logoCMEEfficiency ratio 0.2% vs MIAX's 0.2% (lower = leaner)
Stability / SafetyMIAX logoMIAXLower D/E ratio (0.2% vs 13.1%)
DividendsCME logoCME3.8% yield; 6-year raise streak; the other pay no meaningful dividend
Momentum (1Y)MIAX logoMIAX+61.8% vs CME's +4.6%
Efficiency (ROA)CME logoCMEEfficiency ratio 0.2% vs MIAX's 0.2%

MIAX vs CME — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MIAXMiami International Holdings, Inc.
FY 2025
Transaction And Clearing Fees
87.2%$1.2B
Access Fees
7.8%$106M
Market Data Fees
3.0%$42M
Product and Service, Other
2.0%$27M
CMECME Group Inc.
FY 2025
clearing and transaction fees
81.0%$5.3B
MarketData
12.3%$803M
OtherRevenue
6.7%$436M

MIAX vs CME — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCMELAGGINGMIAX

Income & Cash Flow (Last 12 Months)

CME leads this category, winning 4 of 5 comparable metrics.

CME is the larger business by revenue, generating $6.5B annually — 4.8x MIAX's $1.4B. CME is the more profitable business, keeping 62.0% of every revenue dollar as net income compared to MIAX's -5.1%.

MetricMIAX logoMIAXMiami Internation…CME logoCMECME Group Inc.
RevenueTrailing 12 months$1.4B$6.5B
EBITDAEarnings before interest/tax$105M$4.7B
Net IncomeAfter-tax profit-$70M$4.2B
Free Cash FlowCash after capex$142M$4.4B
Gross MarginGross profit ÷ Revenue+27.3%+86.1%
Operating MarginEBIT ÷ Revenue+2.7%+64.9%
Net MarginNet income ÷ Revenue-5.1%+62.0%
FCF MarginFCF ÷ Revenue+10.6%+64.3%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+10.7%+21.4%
CME leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

CME leads this category, winning 4 of 6 comparable metrics.

On an enterprise value basis, CME's 23.0x EV/EBITDA is more attractive than MIAX's 61.4x.

MetricMIAX logoMIAXMiami Internation…CME logoCMECME Group Inc.
Market CapShares × price$4.6B$104.1B
Enterprise ValueMkt cap + debt − cash$4.1B$103.4B
Trailing P/EPrice ÷ TTM EPS-49.74x25.70x
Forward P/EPrice ÷ next-FY EPS est.34.36x23.49x
PEG RatioP/E ÷ EPS growth rate1.87x
EV / EBITDAEnterprise value multiple61.43x22.96x
Price / SalesMarket cap ÷ Revenue3.34x15.96x
Price / BookPrice ÷ Book value/share3.94x3.60x
Price / FCFMarket cap ÷ FCF31.43x24.82x
CME leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

CME leads this category, winning 5 of 9 comparable metrics.

CME delivers a 15.3% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $-11 for MIAX. MIAX carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to CME's 0.13x. On the Piotroski fundamental quality scale (0–9), MIAX scores 6/9 vs CME's 5/9, reflecting solid financial health.

MetricMIAX logoMIAXMiami Internation…CME logoCMECME Group Inc.
ROE (TTM)Return on equity-11.2%+15.3%
ROA (TTM)Return on assets-6.3%+2.2%
ROICReturn on invested capital+4.2%+10.2%
ROCEReturn on capital employed+4.0%+3.6%
Piotroski ScoreFundamental quality 0–965
Debt / EquityFinancial leverage0.00x0.13x
Net DebtTotal debt minus cash-$508M-$666M
Cash & Equiv.Liquid assets$510M$4.4B
Total DebtShort + long-term debt$2M$3.8B
Interest CoverageEBIT ÷ Interest expense-4.32x41.55x
CME leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CME leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in CME five years ago would be worth $16,450 today (with dividends reinvested), compared to $16,181 for MIAX. Over the past 12 months, MIAX leads with a +61.8% total return vs CME's +4.6%. The 3-year compound annual growth rate (CAGR) favors CME at 19.7% vs MIAX's 17.4% — a key indicator of consistent wealth creation.

MetricMIAX logoMIAXMiami Internation…CME logoCMECME Group Inc.
YTD ReturnYear-to-date+14.0%+9.1%
1-Year ReturnPast 12 months+61.8%+4.6%
3-Year ReturnCumulative with dividends+61.8%+71.4%
5-Year ReturnCumulative with dividends+61.8%+64.5%
10-Year ReturnCumulative with dividends+61.8%+284.9%
CAGR (3Y)Annualised 3-year return+17.4%+19.7%
CME leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — MIAX and CME each lead in 1 of 2 comparable metrics.

CME is the less volatile stock with a -0.30 beta — it tends to amplify market swings less than MIAX's 0.62 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MIAX currently trades 96.8% from its 52-week high vs CME's 87.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMIAX logoMIAXMiami Internation…CME logoCMECME Group Inc.
Beta (5Y)Sensitivity to S&P 5000.62x-0.30x
52-Week HighHighest price in past year$51.38$329.16
52-Week LowLowest price in past year$28.63$257.17
% of 52W HighCurrent price vs 52-week peak+96.8%+87.1%
RSI (14)Momentum oscillator 0–10070.244.1
Avg Volume (50D)Average daily shares traded1.2M2.2M
Evenly matched — MIAX and CME each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates MIAX as "Buy" and CME as "Hold". Consensus price targets imply 11.6% upside for CME (target: $320) vs 2.5% for MIAX (target: $51). CME is the only dividend payer here at 3.81% yield — a key consideration for income-focused portfolios.

MetricMIAX logoMIAXMiami Internation…CME logoCMECME Group Inc.
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$51.00$320.25
# AnalystsCovering analysts535
Dividend YieldAnnual dividend ÷ price+3.8%
Dividend StreakConsecutive years of raises6
Dividend / ShareAnnual DPS$10.92
Buyback YieldShare repurchases ÷ mkt cap+0.5%+0.3%
Insufficient data to determine a leader in this category.
Key Takeaway

CME leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 1 category is tied.

Best OverallCME Group Inc. (CME)Leads 4 of 6 categories
Loading custom metrics...

MIAX vs CME: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is MIAX or CME a better buy right now?

For growth investors, Miami International Holdings, Inc.

(MIAX) is the stronger pick with 19. 6% revenue growth year-over-year, versus 6. 4% for CME Group Inc. (CME). CME Group Inc. (CME) offers the better valuation at 25. 7x trailing P/E (23. 5x forward), making it the more compelling value choice. Analysts rate Miami International Holdings, Inc. (MIAX) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — MIAX or CME?

On forward P/E, CME Group Inc.

is actually cheaper at 23. 5x.

03

Which is the better long-term investment — MIAX or CME?

Over the past 5 years, CME Group Inc.

(CME) delivered a total return of +64. 5%, compared to +61. 8% for Miami International Holdings, Inc. (MIAX). Over 10 years, the gap is even starker: CME returned +284. 9% versus MIAX's +61. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — MIAX or CME?

By beta (market sensitivity over 5 years), CME Group Inc.

(CME) is the lower-risk stock at -0. 30β versus Miami International Holdings, Inc. 's 0. 62β — meaning MIAX is approximately -302% more volatile than CME relative to the S&P 500. On balance sheet safety, Miami International Holdings, Inc. (MIAX) carries a lower debt/equity ratio of 0% versus 13% for CME Group Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — MIAX or CME?

By revenue growth (latest reported year), Miami International Holdings, Inc.

(MIAX) is pulling ahead at 19. 6% versus 6. 4% for CME Group Inc. (CME). On earnings-per-share growth, the picture is similar: CME Group Inc. grew EPS 15. 4% year-over-year, compared to -177. 5% for Miami International Holdings, Inc. . Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — MIAX or CME?

CME Group Inc.

(CME) is the more profitable company, earning 62. 0% net margin versus -5. 1% for Miami International Holdings, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 2. 7% for MIAX. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is MIAX or CME more undervalued right now?

On forward earnings alone, CME Group Inc.

(CME) trades at 23. 5x forward P/E versus 34. 4x for Miami International Holdings, Inc. — 10. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CME: 11. 6% to $320. 25.

08

Which pays a better dividend — MIAX or CME?

In this comparison, CME (3.

8% yield) pays a dividend. MIAX does not pay a meaningful dividend and should not be held primarily for income.

09

Is MIAX or CME better for a retirement portfolio?

For long-horizon retirement investors, CME Group Inc.

(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 30), 3. 8% yield, +284. 9% 10Y return). Both have compounded well over 10 years (CME: +284. 9%, MIAX: +61. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between MIAX and CME?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: MIAX is a small-cap high-growth stock; CME is a mid-cap income-oriented stock. CME pays a dividend while MIAX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

MIAX

High-Growth Disruptor

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Gross Margin > 16%
Run This Screen
Stocks Like

CME

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 37%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform MIAX and CME on the metrics below

Revenue Growth>
%
(MIAX: 19.6% · CME: 6.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.